Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib
CONCLUSIONS: In our cohort of patients with mRCC treated with sunitinib, low LMR (>3) and high PLR (>150) were associated with shorter PFS. Macrocytosis was not prognostic.PMID:34296630 | DOI:10.1177/03008916211033905
Source: Tumori - Category: Cancer & Oncology Authors: Elena Bolzacchini Monica Giordano Lorenza Bert รน Marco Bregni Olga Nigro Luca Galli Andrea Antonuzzo Salvatore Artale Sabrina Barzaghi Marco Danova Martina Torchio Graziella Pinotti Francesco Dentali Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hematology | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Study